Continuous clonidine infusion: an alternative for children on mechanical ventilation

Area of Science:

• Pediatric Critical Care Medicine
• Pharmacology
• Anesthesiology

Background:

• Mechanical ventilation in pediatric intensive care units (PICUs) often requires sedation.
• Clonidine, an alpha-2 adrenergic agonist, is increasingly used for sedation in critically ill children.
• Understanding clonidine's dosing and hemodynamic effects is crucial for safe and effective use.

Purpose of the Study:

• To assess clonidine infusion rates during different phases of mechanical ventilation (initial, maintenance, pre-extubation).
• To evaluate the cumulative dose of other sedatives used concurrently.
• To determine the hemodynamic response to continuous clonidine infusions in pediatric patients.

Main Methods:

• Retrospective cohort study design.
• Inclusion of pediatric patients (up to 2 years) requiring mechanical ventilation and continuous clonidine infusion.
• Analysis of clonidine doses, vasoactive-inotropic scores, heart rate, and blood pressure.

Main Results:

• Median clonidine infusion rates were 0.53 μg/kg/h (first 6h), 0.85 μg/kg/h (maintenance), and 0.63 μg/kg/h (pre-extubation).
• No significant differences in doses were observed based on the indication for mechanical ventilation.
• Clonidine infusion was not associated with significant hemodynamic changes or altered responses when used with adjuvants.

Conclusions:

• Clonidine is a well-tolerated sedation option for pediatric patients undergoing mechanical ventilation.
• Continuous clonidine infusion does not appear to significantly influence hemodynamic variables in this population.
• Further research may explore optimal dosing strategies for specific pediatric critical care scenarios.